Johnson & Johnson ( J&J ) has reduced its Q3 profits from $ 4.8bn to $ 1.8bn , following a recent proposed $ 4bn opioid settlement payment . J&J said it did not know when the settlement would be finalised , but would make any necessary accounting adjustments after the fact . Around 2,600 US lawsuits are outstanding against drug companies in relation to the opioid crisis .
Johnson & Johnson (J&J) has reduced its Q3 profits from $4.8bn to $1.8bn, following a recent proposed $4bn opioid settlement payment. J&J said it did not know when the settlement would be finalised, but would make any necessary accounting adjustments after the fact. Around 2,600 US lawsuits are outstanding against drug companies in relation to the opioid crisis.